U.S. Personal Products Stock News

In May 2026, ANI Pharmaceuticals voluntarily initiated a Class II recall of 3,964 cartons of Estradiol Gel 0.1% across the US after the FDA reported defective packets that were empty or partially filled. At the same time, the company reported strong first-quarter 2026 results, raised its full-year revenue guidance to between US$1.08 billion and US$1.14 billion, and introduced a US$100 million share repurchase program, highlighting management’s confidence despite operational issues. We’ll...

In its recently reported fiscal second quarter, Energizer Holdings posted adjusted earnings that surpassed expectations, helped by tariff refunds and ongoing margin initiatives even as overall net sales declined. Separately, Aqua Capital, Ltd. disclosed an open-market purchase of 38,006 Energizer shares, bringing its direct holding to 7,200,000 shares and underscoring concentrated institutional interest alongside the company’s margin and pricing efforts. We’ll now examine how Energizer’s...

Jack Henry & Associates (NasdaqGS:JKHY) has announced that Board Chair David Foss will retire, with Matt Flanigan named as his successor. The transition follows a long period in which Foss has been closely involved in shaping the company’s direction and governance. For investors tracking NasdaqGS:JKHY, this boardroom change comes at a time when the stock is trading at $130.73 and has been under pressure, with the share price down 26.7% year to date and over the past 1 year. Over longer...

Talos Energy (NYSE:TALO) has closed its Zama transaction, reshaping its offshore Mexico portfolio. The company has secured new Gulf of Mexico leases, expanding its offshore project inventory. Talos reported Q1 results ahead of expectations, supported by strong new well productivity. Talos Energy comes into this news cycle with the stock trading at $15.3 and up 36.0% year to date. The share price is also up 94.2% over the past year, while the 5 year return is down 6.7%. This highlights both...

Wondering if Carrier Global at around US$68.54 is offering fair value or a potential mispricing opportunity? This article breaks down what the current share price might be telling you. The stock has recently moved, with returns of 7.4% over the last week, 6.8% over the last month, and 28.1% year to date. The return over the past year is down 2.6%, and up 56.6% over three years and 60.3% over five years. Recent coverage around Carrier Global has focused on its role in the building and HVAC...

Wondering whether Everpure at US$78.51 is offering good value or asking too much of future expectations? This article walks through what the current price might be implying about the company. The stock has returned 7.5% over the past week, 5.2% over the last month, 13.8% year to date and 43.8% over the past year, with a very large gain over five years of about 4x. Recent coverage around Everpure has focused on its role in the broader tech sector and how investors are reassessing growth...

Recent performance and context for Interparfums (IPAR) Interparfums (IPAR) has been on investors’ radar after a mixed period for the stock, with a modest gain in the past day contrasting with weaker moves over the past week and past 3 months. Over the past month the share price declined about 3%, and over the past 3 months it fell roughly 6%, while the stock is still up about 4% year to date. Over the past year, the total return declined about 33%, and over 3 years it declined about 29%,...

In early June 2026, New Jersey and the city of Newark filed lawsuits against GEO Group over alleged inhumane, unsanitary conditions at the Delaney Hall immigration detention facility and the company’s refusal to allow full state health inspections. The joint legal pressure from state and municipal authorities not only targets Delaney Hall’s operations but also elevates GEO Group’s regulatory and reputational exposure across its broader detention portfolio. We’ll examine how the legal push...

In early June 2026, Samsara Inc. reported first-quarter revenue of US$478.84 million, up from US$366.88 million a year earlier, and moved from a net loss of US$22.12 million to net income of US$44.51 million, with basic and diluted earnings per share both improving from a loss of US$0.04 to earnings of US$0.08. The company also issued guidance pointing to continued revenue growth and ongoing GAAP profitability for the second quarter and full fiscal 2027, highlighting momentum in annual...

Wondering whether Onto Innovation at around US$274.76 is still reasonably priced after its strong run, or if you might be turning up late to the story. The stock has returned 6.2% over the past week, is down 9.9% over the past month, and sits on gains of 65.6% year to date and 191.3% over the past year, which can change how investors think about both upside and risk. Recent coverage around Onto Innovation has focused on its role within the semiconductor sector and how investors are reacting...

Swarmer (NasdaqCM:SWMR) and Powerus have signed a Memorandum of Understanding to integrate Swarmer’s drone autonomy software into air and maritime autonomous systems. The collaboration targets defense, counter UAS, border security, and critical infrastructure protection use cases. The agreement extends Swarmer’s technology beyond its core drone market into broader multi domain autonomous platforms. Swarmer, trading at $72.81 under ticker NasdaqCM:SWMR, is coming off strong recent share...

Recent performance snapshot Principal Financial Group (PFG) has drawn attention after recent share price moves, with the stock last closing at US$103.51. Investors are weighing this level against its recent returns, profitability profile, and current valuation signals. See our latest analysis for Principal Financial Group. The recent 2.3% 1 day share price return adds to a steady trend, with a 90 day share price return of 12.2% and a 5 year total shareholder return of 92.2%. This indicates...

At the 2026 American Thoracic Society conference held earlier this year, Insmed showcased encouraging post‑hoc Phase III data for Brinsupri, its first‑to‑market DPP‑1 inhibitor for non‑cystic fibrosis bronchiectasis, while also granting inducement stock awards to 103 new employees under its 2025 Inducement Plan. The combination of positive clinical signals for Brinsupri and expanded equity‑based hiring underscores Insmed’s effort to build both medical leadership and internal capabilities...

MBX Biosciences recently outlined its participation at the Jefferies Global Healthcare Conference in New York and scheduled a June 12, 2026 investor webcast and call to discuss new once-weekly canvuparatide data from ENDO 2026, including one-year open-label extension and full 12-week Phase 2 Avail trial results. These upcoming endocrinology-focused presentations highlight canvuparatide’s central role in MBX Biosciences’ pipeline and could refine how investors assess the company’s clinical...

Cinemark Holdings reported that May 2026 delivered its highest-ever domestic box office results, supported by a varied film slate and strong turnout, especially from younger audiences. The company also achieved record food and beverage spending per guest, underlining how concession monetization is becoming an increasingly powerful earnings driver alongside ticket sales. Next, we’ll examine how this record May performance, particularly the surge in concession spending, may influence...

Wondering if Ulta Beauty at US$462.52 is starting to look like value or if the stock still has more risk priced in? This article breaks down what the current share price might be implying. The stock has had a rough patch recently, with the share price falling 11.1% over the last week, 13.1% over the last month, and 25.4% year to date. The return over the last year is a smaller decline of 1.0%, and the 3 and 5 year returns are gains of 10.4% and 39.3% respectively. These moves sit against a...

In early June 2026, Core Natural Resources released its latest investor presentation, reporting Q1 2026 revenue of US$1.10 billion, Adjusted EBITDA of US$179.9 million, net operating cash flow of US$119.4 million, free cash flow of US$55.5 million, and total liquidity of US$935.4 million. The company also returned US$47.0 million to shareholders in the quarter, underlining its focus on capital returns alongside maintaining substantial liquidity. We’ll now examine how this strong Q1 free cash...

Freshpet (FRPT) is back in focus after being flagged on June 3 as the consumer staples stock with the highest short interest, paired with recent insider share sales and, in contrast, constructive fundamental assessments. See our latest analysis for Freshpet. Despite the recent short interest spotlight and insider selling, Freshpet’s share price has fallen 18.2% over the past month and 40.4% over the past quarter, while the 1 year total shareholder return is down 39.2%. This suggests momentum...

Kinsale Capital Group recently reported mixed first-quarter results, with revenue rising year over year but coming in below analyst expectations, highlighting the challenges of insuring hard-to-place and higher-risk clients. This earnings outcome has prompted investors to reassess how Kinsale’s niche focus and underwriting approach might influence its longer-term business prospects. We’ll now explore how Kinsale’s revenue shortfall against expectations may influence its investment narrative...

Recent performance snapshot AerCap Holdings (AER) has drawn fresh attention after recent trading left the stock down about 6% over the past month, even as its past 3 months return is roughly flat. For investors tracking the aircraft leasing sector, this short term pullback sits against a backdrop of a 19% total return over the past year and multi year gains that are several times higher than that. See our latest analysis for AerCap Holdings. Recent trading shows momentum cooling, with the...

CSX (CSX) is drawing fresh attention after being named Nissan’s 2026 Supply Chain Management Partner of the Year, a recognition that sits alongside recent stock outperformance and improving full year earnings estimates. See our latest analysis for CSX. Beyond the Nissan recognition, CSX’s share price has been firming, with a 30 day share price return of 2.66% and a 90 day share price return of 15.72%. The 1 year total shareholder return of 47.71% points to strong momentum over a longer...

In early June 2026, Camtek Ltd. reported receiving more than US$105,000,000 in combined multi-system orders from a tier-1 OSAT and a leading HBM manufacturer for AI-related semiconductor inspection and metrology tools, with deliveries expected in 2027. This concentration of large, AI-focused orders from top-tier packaging and memory customers highlights how central Camtek’s Hawk platform and inspection capabilities have become in advanced AI and high-performance computing supply...

Recent Share Performance and Business Context Ionis Pharmaceuticals (IONS) has drawn attention after recent trading, with the stock last closing at $75.13. The move comes against a backdrop of mixed short term returns and a longer track record of positive total returns. See our latest analysis for Ionis Pharmaceuticals. Short term trading has been choppy, with a 1 day share price gain of 1.77% set against weaker recent share price returns year to date, while the 1 year total shareholder...

Event context and recent share performance MKS (MKSI) has drawn investor attention after recent share price moves, with the stock down 1.5% over the past day but up around 2.1% over the past week. See our latest analysis for MKS. While the 1-day share price return is down 1.47%, MKS has shown strong momentum recently, with a 30-day share price return of 14.80%, a 90-day share price return of 57.25%, and a 1-year total shareholder return of 280.91%. This points to shifting expectations around...